Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha

被引:23
|
作者
Li, Guolin [1 ,2 ,3 ]
Brocker, Chad N. [1 ]
Yan, Tingting [1 ]
Xie, Cen [1 ]
Krausz, Kristopher W. [1 ]
Xiang, Rong [4 ,5 ]
Gonzalez, Frank J. [1 ]
机构
[1] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] Hunan Normal Univ, Coll Life Sci, Lab Aging Biochem, Changsha 410081, Hunan, Peoples R China
[3] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Hunan, Peoples R China
[4] Cent S Univ, State Key Lab Med Genet, Changsha 41001, Hunan, Peoples R China
[5] Cent S Univ, Sch Life Sci, Changsha 41001, Hunan, Peoples R China
来源
MOLECULAR METABOLISM | 2018年 / 7卷
基金
美国国家卫生研究院;
关键词
PPARA; PPARalpha; Intermittent fasting; Every-other-day fasting; Steatosis; Adaptive fasting response; FATTY-ACID OXIDATION; PPAR-ALPHA; HEPATIC STEATOSIS; LIVER-DISEASE; LIPID-METABOLISM; MICE; PHYSIOLOGY; MOUSE; MODEL; OBESITY;
D O I
10.1016/j.molmet.2017.10.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Peroxisome proliferator-activated receptor alpha (PPARA) is a major regulator of fatty acid oxidation and severe hepatic steatosis occurs during acute fasting in Ppara-null mice. Thus, PPARA is considered an important mediator of the fasting response; however, its role in other fasting regiments such as every-other-day fasting (EODF) has not been investigated. Methods: Mice were pre-conditioned using either a diet containing the potent PPARA agonist Wy-14643 or an EODF regimen prior to acute fasting. Ppara-null mice were used to assess the contribution of PPARA activation during the metabolic response to EODF. Livers were collected for histological, biochemical, qRT-PCR, and Western blot analysis. Results: Acute fasting activated PPARA and led to steatosis, whereas EODF protected against fasting-induced hepatic steatosis without affecting PPARA signaling. In contrast, pretreatment with Wy-14,643 did activate PPARA signaling but did not ameliorate acute fasting-induced steatosis and unexpectedly promoted liver injury. Ppara ablation exacerbated acute fasting-induced hypoglycemia, hepatic steatosis, and liver injury in mice, whereas these detrimental effects were absent in response to EODF, which promoted PPARA-independent fatty acid metabolism and normalized serum lipids. Conclusions: These findings indicate that PPARA activation prior to acute fasting cannot ameliorate fasting-induced hepatic steatosis, whereas EODF induced metabolic adaptations to protect against fasting-induced steatosis without altering PPARA signaling. Therefore, PPARA activation does not mediate the metabolic adaptation to fasting, at least in preventing acute fasting-induced steatosis. Published by Elsevier GmbH.
引用
收藏
页码:80 / 89
页数:10
相关论文
共 50 条
  • [41] Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis
    Honda, Yasushi
    Kessoku, Takaomi
    Ogawa, Yuji
    Tomeno, Wataru
    Imajo, Kento
    Fujita, Koji
    Yoneda, Masato
    Takizawa, Toshiaki
    Saito, Satoru
    Nagashima, Yoji
    Nakajima, Atsushi
    SCIENTIFIC REPORTS, 2017, 7
  • [42] Peroxisome proliferator-activated regulation of lipid metabolism by receptor α is involved in the ginseng
    Yoon, M
    Lee, H
    Jeong, S
    Kim, JJ
    Nicol, CJ
    Nam, KW
    Kim, M
    Cho, BG
    Oh, GT
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 (07) : 1295 - 1302
  • [43] Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ
    Takai, Shinji
    Jin, Denan
    Miyazaki, Mizuo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 116 (03) : 309 - 315
  • [44] The Contribution of Peroxisome Proliferator-Activated Receptor Alpha to the Relationship Between Toxicokinetics and Toxicodynamics of Trichloroethylene
    Yoo, Hong Sik
    Cichocki, Joseph A.
    Kim, Sungkyoon
    Venkatratnam, Abhishek
    Iwata, Yasuhiro
    Kosyk, Oksana
    Bodnar, Wanda
    Sweet, Stephen
    Knap, Anthony
    Wade, Terry
    Campbell, Jerry
    Clewell, Harvey J.
    Melnyk, Stepan B.
    Chiu, Weihsueh A.
    Rusyn, Ivan
    TOXICOLOGICAL SCIENCES, 2015, 147 (02) : 339 - 349
  • [45] Exploring compounds to be used as cosmetic agents that activate peroxisome proliferator-activated receptor alpha
    Tachibana, Keisuke
    Fukuda, Syohei
    Fukushima, Jun
    Ishimoto, Kenji
    Sakata, Masahiro
    Nishimori, Yasutomo
    Doi, Takefumi
    INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, 2022, 44 (02) : 189 - 200
  • [46] Peroxisome Proliferator-Activated Receptor Alpha Mediates the Beneficial Effects of Atorvastatin in Experimental Colitis
    Basso, Paulo Jose
    Sales-Campos, Helioswilton
    Nardini, Viviani
    Duarte-Silva, Murillo
    Freitas Alves, Vanessa Beatriz
    Bonfa, Giuliano
    Rodrigues, Cassiano Costa
    Ghirotto, Bruno
    Lazo Chica, Javier Emilio
    Nomizo, Auro
    de Barros Cardoso, Cristina Ribeiro
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [47] Catalposide is a natural agonistic ligand of peroxisome proliferator-activated receptor-α
    Lee, Ji Hae
    Jun, Hee-jin
    Hoang, Minh-Hien
    Jia, Yaoyao
    Han, Xiang Hua
    Lee, Dong-Ho
    Lee, Hak-Ju
    Hwang, Bang Yeon
    Lee, Sung-Joon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (04) : 568 - 572
  • [48] Roles of peroxisome proliferator-activated receptor α in the pathogenesis of ethanol-induced liver disease
    Meng, Fan-Ge
    Zhang, Xiu-Ning
    Liu, Shi-Xuan
    Wang, Yi-Ran
    Zeng, Tao
    CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 327
  • [49] Involvement of Peroxisome Proliferator-Activated Receptor-Alpha in Liver Tumor Production by Permethrin in the Female Mouse
    Kondo, Miwa
    Miyata, Kaori
    Nagahori, Hirohisa
    Sumida, Kayo
    Osimitz, Thomas G.
    Cohen, Samuel M.
    Lake, Brian G.
    Yamada, Tomoya
    TOXICOLOGICAL SCIENCES, 2019, 168 (02) : 572 - 596
  • [50] Hepatic fibrosis: targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines
    Gong, Lijun
    Wei, Fang
    Gonzalez, Frank J.
    Li, Guolin
    HEPATOLOGY, 2023, 78 (05) : 1625 - 1653